肌少症在肝硬化之臨床意義與治療

10.6666/ClinMed.202103_87(3).0028

吳佩珊；李癸汌

肌少症（sarcopenia） ； 肝硬化（liver cirrhosis） ； 氨（ammonia）

臨床醫學月刊

87卷3期（2021 / 03 / 26）

174 - 179

繁體中文

肌少症是骨骼肌流失導致的肌肉病變，在肝硬化患者中的盛行率頗高，並且會影響病患的存活率、生活品質、其他肝硬化相關併發症的發生以及肝移植後預後。目前診斷肝硬化肌少症主要是使用影像學來做為診斷工具。飲食調整、支鏈胺基酸補充、降氨藥物使用與荷爾蒙補充都可作為改善肌少症的治療方式。本文整理了肌少症的病生理、診斷與治療方式。

1. (2019).EASL Clinical Practice Guidelines on nutrition in chronic liver disease.J Hepatol,70,172-193.
2. Bergerson, JT,Lee, JG,Furlan, A(2015).Liver transplantation arrests and reverses muscle wasting.Clin Transplant,29,216-221.
3. Beyer, I,Mets, T,Bautmans, I(2012).Chronic low-grade inflammation and age-related sarcopenia.Curr Opin Clin Nutr Metab Care,15,12-22.
4. Bhanji, RA,Moctezuma-Velazquez, C,Duarte-Rojo, A(2018).Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.Hepatol International,12,377-386.
5. Campillo, B,Bories, PN,Pornin, B(1997).Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis.Nutrition,13,613-621.
6. Dasarathy, J,Alkhouri, N,Dasarathy, S(2011).Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.Liver Int,31,1250-1258.
7. DiMartini, A,Cruz, RJ, Jr,Dew, MA(2013).Muscle mass predicts outcomes following liver transplantation.Liver Transpl,19,1172-1180.
8. Drummond, MJ,Dreyer, HC,Fry, CS(2009).Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling.J Appl Physiol(Bethesda, Md. : 1985),106,1374-1384.
9. Ebadi, M,Tandon, P,Moctezuma-Velazquez, C(2018).Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.J Hepatol,69,608-616.
10. Frost, RA,Lang, CH(2012).Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.Endocrinol Metab Clin North Am,41,297-322.
11. Garcia, PS,Cabbabe, A,Kambadur, R(2010).Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting.Anesth Analg,111,707-709.
12. Ha, Y,Kim, D,Han, S(2018).Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.Cancer Res Treat,50,843-851.
13. Kamo, N,Kaido, T,Hamaguchi, Y(2019).Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.Clin Nutr,38,2202-2209.
14. Kumar, A,Davuluri, G,Silva, RNE(2017).Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.Hepatology,65,2045-2058.
15. Meza-Junco, J,Montano-Loza, AJ,Baracos, VE(2013).Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.J Clin Gastroenterol,47,861-870.
16. Montano-Loza, AJ,Duarte-Rojo, A,Meza-Junco, J(2015).Inclusion of Sarcopenia Within MELD(MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis.Clin Transl Gastroenterol,6,e102.
17. Montano-Loza, AJ,Meza-Junco, J,Baracos, VE(2014).Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.Liver Transpl,20,640-648.
18. Montano-Loza, AJ,Meza-Junco, J,Prado, CM(2012).Muscle wasting is associated with mortality in patients with cirrhosis.Clin Gastroenterol Hepatol,10,166-173.
19. Morrison, WL,Bouchier, IA,Gibson, JN(1990).Skeletal muscle and whole-body protein turnover in cirrhosis.Clin Sci,78,613-619.
20. Okuda, H,Shiratori, K(2007).Long-term nutritional assessment and quality of life in patients with cirrhosis taking a late evening snack.J Gastroenterol,42,186-187.
21. Picardi, A,Oliveira, AC,Muguerza, B(1997).Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis.J Hepatol,26,191-202.
22. Shen, W,Punyanitya, M,Wang, Z(2004).Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image.J Appl Physiol,97,2333-2338.
23. Sinclair, M,Grossmann, M,Hoermann, R(2016).Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial.J Hepatol,65,906-913.
24. Tsien, C,Garber, A,Narayanan, A(2014).Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.J Gastroenterology Hepatology,29,1250-1257.
25. Tsien, C,Shah, SN,McCullough, AJ(2013).Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.Eur J Gastroenterol Hepatol,25,85-93.
26. van Vugt, JLA,Alferink, LJM,Buettner, S(2018).A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.J Hepatol,68,707-714.